How to Leverage Genomic Testing to Guide Precision Medicine in Prostate Cancer
Precision medicine is finally gaining traction in prostate cancer owing to advances in genetic testing.
Related Articles
ASCO Statement on FDA Issuing Final Rule Regulating IVDs
The Food and Drug Administration (FDA) released a final rule April 29 that regulates laboratory-developed tests the same as other in vitro diagnostic tests. This…
Program Guide – ASCO Meeting Program Guide
1 – 20 out of 5893 Results for “2024 ASCO Annual Meeting” 5893 Results Select All Presenter: Jens Hoeppner, FAChirg, FACS, MD Presenter: Christian U.…
Expanded Oncology Summer Internship Program Targets Increased
The American Society of Clinical Oncology (ASCO) announced four additional medical schools have been selected to participate in the Society’s Oncology Summer Internship (OSI) Program.
Exploring Current Immunotherapy Treatment Approaches in Resectable Non–Small Cell Lung Cancer
With improved survival benefits with ICIs and targeted therapies in metastatic NSCLC, the use of these agents has made its way into early-stage NSCLC.
To Provide Quality Cancer Care, Clinicians Must Appreciate the People Living With the Disease
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.
New Collaborative Guideline Highlights the Importance of Multidisciplinary Care for Patients With Osteoradionecrosis
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance…
Glecirasib Demonstrates Encouraging Efficacy and Safety in KRASG12C-Mutated NSCLC in Phase 2 Trial From China
Data from a single-arm phase 2 trial conducted in China showed that glecirasib produced a response rate of 48% in patients with advanced KRASG12C-mutated NSCLC…
ASCO Plenary Series Program
Learn more about the faculty and program for the Monthly Plenary Series session.